Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/209210
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFerré, Adriana-
dc.contributor.authorSantiago, Lucía-
dc.contributor.authorSánchez Herrero, José Francisco-
dc.contributor.authorLópez Rodrigo, Olga-
dc.contributor.authorSánchez Curbelo, Josvany-
dc.contributor.authorSumoy, Lauro-
dc.contributor.authorBassas, Lluís-
dc.contributor.authorLarriba, Sara-
dc.date.accessioned2024-03-26T19:43:42Z-
dc.date.available2024-03-26T19:43:42Z-
dc.date.issued2023-10-21-
dc.identifier.issn1422-0067-
dc.identifier.urihttps://hdl.handle.net/2445/209210-
dc.description.abstractSmall RNA-sequencing (small RNA-seq) has revealed the presence of small RNA-naturally occurring variants such as microRNA (miRNA) isoforms or isomiRs. Due to their small size and the sequence similarity among miRNA isoforms, their validation by RT-qPCR is challenging. We previously identified two miR-31-5p isomiRs-the canonical and a 3 ' isomiR variant (3 ' G addition)-which were differentially expressed between individuals with azoospermia of different origin. Here, we sought to determine the discriminatory capacity between these two closely-related miRNA isoforms of three alternative poly(A) based-RT-qPCR strategies in both synthetic and real biological context. We found that these poly(A) RT-qPCR strategies exhibit a significant cross-reactivity between these miR-31-5p isomiRs which differ by a single nucleotide, compromising the reliable quantification of individual miRNA isoforms. Fortunately, in the biological context, given that the two miRNA variants show changes in the same direction, RT-qPCR results were consistent with the findings of small RNA-seq study. We suggest that miRNA selection for RT-qPCR validation should be performed with care, prioritizing those canonical miRNAs that, in small RNA-seq, show parallel/homogeneous expression behavior with their most prevalent isomiRs, to avoid confounding RT-qPCR-based results. This is suggested as the current best strategy for robust biomarker selection to develop clinically useful tests.-
dc.format.extent14 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherMDPI AG-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/ijms242015436-
dc.relation.ispartofInternational Journal of Molecular Sciences, 2023, vol. 24, num. 20-
dc.relation.urihttps://doi.org/10.3390/ijms242015436-
dc.rightscc by (c) Ferré, Adriana et al., 2023-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))-
dc.subject.classificationMicro RNAs-
dc.subject.classificationCàncer-
dc.subject.otherMicroRNAs-
dc.subject.otherCancer-
dc.title3′IsomiR Species Composition Affects Reliable Quantification of miRNA/isomiR Variants by Poly(A) RT-qPCR: Impact on Small RNA-Seq Profiling Validation-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.date.updated2023-11-16T10:16:22Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid37895116-
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
ijms-24-15436-v3.pdf1.07 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons